ROLE OF METHAMPHETAMINE METABOLISM IN THE DEVELOPMENT OF CNS TOLERANCE TO THE DRUG

被引:0
|
作者
ALBURGES, ME
HANSON, GR
GIBB, JW
机构
来源
INVESTIGACION CLINICA | 1990年 / 31卷 / 04期
关键词
METHAMPHETAMINE (METH); AMPHETAMINE (AMP); TOLERANCE; METABOLISM;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We have previously observed that pretreatment with increasing doses of methamphetamine (METH) attenuates the effects of METH on the dopaminergic and serotonergic systems as compared with the ones observed in nonpretreated controls. In order to understand the mechanism of this tolerance, untreated rats (naive) and rats pretreated with METH (daily doses of 2.5, 5.0, 7.5, and 10 mg/kg, s.c., at 6h intervals with a 24h drug-free period between each dose) were challenged with the administration of 5 doses of METH (15 mg/kg, s.c., at 6h intervals). The metabolism of METH in brain, liver, and blood was studied by measuring the concentration of METH and its metabolites 2, 4, 6, 8 and 10h after the last dose by gas chromatography/mass spectrometry techniques.
引用
收藏
页码:165 / 176
页数:12
相关论文
共 50 条
  • [42] TOLERANCE DEVELOPMENT TO CHRONIC METHAMPHETAMINE INTOXICATION IN RHESUS-MONKEY
    FISCHMAN, MW
    SCHUSTER, CR
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1974, 2 (04) : 503 - 508
  • [43] CNS Drug Development: Part I: The Early Period of CNS Drugs
    Preskorn, Sheldon H.
    JOURNAL OF PSYCHIATRIC PRACTICE, 2010, 16 (05) : 334 - 339
  • [44] A role for academic institutions in CNS drug discovery
    Conn, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 2 - 2
  • [45] Recent Update on Pharmacokinetics and Drug Metabolism in CNS-based Drug Discovery
    Sanap, Sachin Nashik
    Bisen, Amol Chhatrapati
    Kedar, Ashwini
    Agrawal, Sristi
    Bhatta, Rabi Sankar
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (20) : 1602 - 1616
  • [46] Drug metabolism in drug discovery and development
    Zhoupeng Zhang
    Wei Tang
    Acta Pharmaceutica Sinica B, 2018, 8 (05) : 721 - 732
  • [47] Drug metabolism in drug discovery and development
    Zhang, Zhoupeng
    Tang, Wei
    ACTA PHARMACEUTICA SINICA B, 2018, 8 (05) : 721 - 732
  • [48] Impact of regulatory issues on drug development for the CNS
    Kuruma, I
    PRECLINICAL AND CLINICAL STRATEGIES FOR THE TREATMENT OF NEURODEGENERATIVE, CEREBROVASCULAR AND MENTAL DISORDERS, 1996, 11 : 281 - 282
  • [49] Targeted to neuronal organelles for CNS drug development
    Ying, Zheng
    Ye, Na
    Ma, Qilian
    Chen, Fan
    Li, Ningning
    Zhen, Xuechu
    ADVANCED DRUG DELIVERY REVIEWS, 2023, 200
  • [50] New Era for Novel CNS Drug Development
    Potter, William Z.
    NEUROPSYCHOPHARMACOLOGY, 2012, 37 (01) : 278 - 280